CTRI/2020/11/029437尚未招募不适用
A retrospective study to evaluate clinical and radiological course in COVID 19 interstitial pneumonia.
Medanta Institute of Education and Research1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2020年12月15日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 300
- 试验地点
- 1
- 主要终点
- High-resolution computed tomography (HRCT) features of COVID 19 at presentation and 12 weeks later
研究概览
简要总结
This is a retrospective de-identified observational study to monitor the clinical and radiological course in patients with moderate or severe COVID-19 interstitial pneumonia and to study the changes in Computed Tomography findings after four weeks. Patients confirmed with COVID-19, admitted to Medanta-The Medicity and patients with moderate or severe COVID 19 pneumonia, admitted to ward or ICU will be included in the study.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18.00 Year(s) 至 80.00 Year(s)（—）
- 性别
- All
入选标准
- •Patients confirmed with COVID-19, admitted to Medanta-The Medicity, Gurgaon, India.
- •Patients with moderate or severe COVID 19 pneumonia, admitted to ward or ICU.
排除标准
- •Age <18 years
- •Patients with mild COVID 19
- •Pregnant female
- •Patients with history of COVID-19 Interstitial Pneumonia treatment.
结局指标
主要结局
High-resolution computed tomography (HRCT) features of COVID 19 at presentation and 12 weeks later
时间窗: High-resolution computed tomography (HRCT) features of COVID 19 at presentation and 12 weeks later
次要结局
- Effect of therapy used(Role of anti-fibrotic medications)
研究者
研究点 (1)
Loading locations...
相似试验
尚未招募
不适用
A study to evaluate post COVID-19 lung damage.CTRI/2020/11/029437Medanta Institute of Education and Research
已完成
不适用
Clinical-biological Characteristics and Outcome of Chronic Lymphocytic Leukemia Under Ibrutinib-named Patient ProgramChronic Lymphocytic LeukemiaNCT02582320Gruppo Italiano Malattie EMatologiche dell'Adulto264
已完成
不适用
Retrospective Observational Study Investigating Fluciclovine (18F) (FACBC)Prostatic NeoplasmsNCT02443571Blue Earth Diagnostics714
已完成
不适用
Characterize and Assess Clinical Outcomes of Patients Receiving Tezepelumab After Marketing Approval in SpainAsthmaNCT07013760AstraZeneca420
未知
不适用
Retrospective study for examine the clinical feature and the incidence of neuroblastoma with opsoclonus-myoclonus syndromeneuroblastomaJPRN-UMIN000017849Japan neuroblastoma study group